Home › Funds › MPM BioImpact LLC › ANL
MPM BioImpact LLC position in ANL
ADLAI NORTYE GROUP LTD · Health Care
MPM BioImpact LLC reported holding 1,936,291 shares of ANL (ADLAI NORTYE GROUP LTD) in its Q2 2026 13F filing — a position valued at US$22.3M, representing 1.36% of its reported portfolio and ranking #27 among its reported holdings. MPM BioImpact LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's ANL position evolved
MPM BioImpact LLC first disclosed a stake in ANL in Q2 2026 at 1,936,291 shares (US$22.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.94M | $22.27M | New |
About ANL and 13F data
ANL (ADLAI NORTYE GROUP LTD) is a Health Care company. 41 other funds we track also report a position in ANL — the largest reported positions include Cormorant Asset Management, LP (US$45.7M), Venrock Adviser, LLC (US$36.9M), Casdin Capital (US$14.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANL
- Cormorant Asset Management, LP 3.98M sh · $45.75M · Q2 2026
- Venrock Adviser, LLC 3.21M sh · $36.95M · Q2 2026
- Casdin Capital 1.25M sh · $14.38M · Q2 2026
- ADAR1 Capital Management, LLC 1.02M sh · $11.70M · Q2 2026
- Octagon Capital Advisors LP 934.72K sh · $10.75M · Q2 2026
- Squadron Capital Management LLC 764.88K sh · $8.80M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 552.50K sh · $6.35M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 258.39K sh · $2.97M · Q2 2026
- DAFNA Capital Management LLC 239.55K sh · $2.75M · Q2 2026
- Kalehua Capital Management LLC 226.41K sh · $2.60M · Q2 2026
- ACT CAPITAL MANAGEMENT, LLC 27.00K sh · $310.50K · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held ANL?
MPM BioImpact LLC has disclosed ANL holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is MPM BioImpact LLC's current position in ANL?
As of Q2 2026, MPM BioImpact LLC holds 1.94M shares of ANL (ADLAI NORTYE GROUP LTD), valued at $22.27M, representing 1.36% of its reported portfolio and ranking #27.
Has MPM BioImpact LLC been buying or selling ANL?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC newly opened its position in ANL.
Which other funds hold ANL?
Other major institutional holders of ANL include Cormorant Asset Management, LP, Venrock Adviser, LLC, Casdin Capital, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.